Publications by authors named "Tetsuhiro Kyo"
[Photodynamic therapy in age-related macular degeneration: one-year results].
Nippon Ganka Gakkai Zasshi
October 2008
Purpose: To evaluate the efficacy of photodynamic therapy (PDT) for subfoveal choroidal neovascularization(CNV) secondary to age-related macular degeneration(AMD) one year after PDT.
Patients And Methods: 106 eyes of 106 AMD patients with subfoveal CNV detected by fluorescein angiography (FA). Best-corrected visual acuity, color fundus photography, FA and indocyanine green angiography were performed before and 1 year after treatment.
Objective: To evaluate quality of life(QOL) in patients who underwent photodynamic therapy (PDT) for subfoveal choroidal neovascularization (CNV) of age-related macular degeneration (AMD), and to clarify factors influencing QOL.
Methods: 77 patients who had undergone PDT for subfoveal CNV of AMD were interviewed to evaluate QOL within 1 week before PDT, and 1 year after PDT. Subscale QOL scores were calculated and compared at these two time points.
Objective: To quantify quality of life (QOL) changes in patients who have received a single session of photodynamic therapy (PDT) for subfoveal choroidal neovascularization, secondary to age-related macular degeneration (AMD), and to identify factors that correlate with the QOL changes.
Methods: The QOL changes in 88 patients with AMD were scored with the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25) before and 3 months after a single PDT with routine ophthalmologic examinations. We used multiple regression analysis to evaluate VFQ-25 sub-scale scores and ophthalmologic findings in these patients before PDT, to identify impact on the effectiveness of PDT.
Purpose: To evaluate the 3-month effects after one-time photodynamic therapy (PDT) for subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD).
Subjects And Methods: The subjects were 122 patients with subfoveal CNV due to AMD detected by fluorescein angiography (FA). FA, indocyanine-green angiography (IA), and the examination of visual acuity were done before and 3 months after PDT.